These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 23457024)

  • 1. A note on the expected biases in conventional iterative health state valuation protocols.
    Ternent L; Tsuchiya A
    Med Decis Making; 2013 May; 33(4):544-6. PubMed ID: 23457024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The measurement of contingent valuation for health economics.
    Bayoumi AM
    Pharmacoeconomics; 2004; 22(11):691-700. PubMed ID: 15250748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individual differences in the use of the response scale determine valuations of hypothetical health states: an empirical study.
    Essink-Bot ML; Stuifbergen MC; Meerding WJ; Looman CW; Bonsel GJ;
    BMC Health Serv Res; 2007 Apr; 7():62. PubMed ID: 17466068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Corrective Approach: Policy Implications of Recent Developments in QALY Measurement Based on Prospect Theory.
    Lipman SA; Brouwer WBF; Attema AE
    Value Health; 2019 Jul; 22(7):816-821. PubMed ID: 31277829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aiding priority setting in health care: is there a role for the contingent valuation method?
    Olsen JA
    Health Econ; 1997; 6(6):603-12. PubMed ID: 9466142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How can we value an environmental asset that very few have visited or heard of? Lessons learned from applying contingent and inferred valuation in an Australian wetlands case study.
    Gregg D; Wheeler SA
    J Environ Manage; 2018 Aug; 220():207-216. PubMed ID: 29778957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there a case for using visual analogue scale valuations in cost-utility analysis?
    Parkin D; Devlin N
    Health Econ; 2006 Jul; 15(7):653-64. PubMed ID: 16498700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contingent valuation method in health care.
    Klose T
    Health Policy; 1999 May; 47(2):97-123. PubMed ID: 10538292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protocols for time tradeoff valuations of health states worse than dead: a literature review.
    Tilling C; Devlin N; Tsuchiya A; Buckingham K
    Med Decis Making; 2010; 30(5):610-9. PubMed ID: 20068144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health outcomes in economic evaluation: who should value health?
    Stamuli E
    Br Med Bull; 2011; 97():197-210. PubMed ID: 21285110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reconsidering the use of rankings in the valuation of health states: a model for estimating cardinal values from ordinal data.
    Salomon JA
    Popul Health Metr; 2003 Dec; 1(1):12. PubMed ID: 14687419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of contemporaneous EQ-5D and SF-6D responses using scoring algorithms derived from similar valuation exercises.
    Whitehurst DG; Norman R; Brazier JE; Viney R
    Value Health; 2014 Jul; 17(5):570-7. PubMed ID: 25128050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience-Based Values: A Framework for Classifying Different Types of Experience in Health Valuation Research.
    Cubi-Molla P; Shah K; Burström K
    Patient; 2018 Jun; 11(3):253-270. PubMed ID: 29305706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Empirical Study of Two Alternative Comparators for Use in Time Trade-Off Studies.
    Shah K; Mulhern B; Longworth L; Janssen MF
    Value Health; 2016 Jan; 19(1):53-9. PubMed ID: 26797236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of 3 valuation methods for temporary health states in patients treated with oral anticoagulants.
    Locadia M; Stalmeier PF; Oort FJ; Prins MH; Sprangers MA; Bossuyt PM
    Med Decis Making; 2004; 24(6):625-33. PubMed ID: 15534343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-state valuations for pertussis: methods for valuing short-term health states.
    Lee GM; Salomon JA; LeBaron CW; Lieu TA
    Health Qual Life Outcomes; 2005 Mar; 3():17. PubMed ID: 15780145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing contingent valuation and contingent ranking: a case study considering the benefits of urban river water quality improvements.
    Bateman IJ; Cole MA; Georgiou S; Hadley DJ
    J Environ Manage; 2006 May; 79(3):221-31. PubMed ID: 16183194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appraising the use of contingent valuation: a note in response.
    Fox-Rushby J
    Health Econ; 1993 Dec; 2(4):361-2; discussion 363-5. PubMed ID: 8142998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the equivalence of collectively and individually collected responses: standard-gamble and time-tradeoff judgments of health states.
    Krabbe PF; Essink-Bot ML; Bonsel GJ
    Med Decis Making; 1996; 16(2):120-32. PubMed ID: 8778530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.